Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 557,392 |
|
|||||
| News | - | ||||||
| Day High | 4.625 | Low High |
|||||
| Day Low | 4.535 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| OmniAb Inc | OABI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.08 | -1.72% | 4.56 | 19:52:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.62 | 4.535 | 4.625 | 4.56 | 4.64 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,681 | 557,392 | $ 4.58 | $ 2,550,190 | - | 3.14 - 6.715 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:33:42 | 50 | $ 4.56 | USD |
OmniAb Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 528.88M | 116.24M | - | 34.16M | -50.62M | -0.44 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
OmniAb News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OABI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.83 | 4.86 | 4.5219 | 4.66 | 652,198 | -0.27 | -5.59% |
| 1 Month | 5.24 | 5.5429 | 4.5219 | 5.06 | 540,780 | -0.68 | -12.98% |
| 3 Months | 6.01 | 6.5488 | 4.5219 | 5.38 | 488,173 | -1.45 | -24.13% |
| 6 Months | 4.75 | 6.715 | 4.17 | 5.34 | 511,487 | -0.19 | -4.00% |
| 1 Year | 3.83 | 6.715 | 3.14 | 5.08 | 519,464 | 0.73 | 19.06% |
| 3 Years | 5.07 | 6.715 | 1.91 | 4.10 | 741,635 | -0.51 | -10.06% |
| 5 Years | 5.07 | 6.715 | 1.91 | 4.10 | 741,635 | -0.51 | -10.06% |
OmniAb Description
| OmniAb Inc offers best-in-class therapeutic antibody discovery technologies. |
